Viewing Study NCT01660750


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-28 @ 4:28 AM
Study NCT ID: NCT01660750
Status: COMPLETED
Last Update Posted: 2017-10-18
First Post: 2012-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma
Sponsor: Criterium, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None newly diagnosed multiple myeloma View
None transplant eligible multiple myeloma View